MYROVLYTIS TRUST
Promote research into rare disorders and advance education of the public in medical and molecular genetics.
Objects
3.1 THE ADVANCEMENT AND PROMOTION OF RESEARCH INTO RARE DISORDERS IN ORDER TO BETTER UNDERSTAND, DIAGNOSE, PREVENT, CURE AND RELIEVE CONDITIONS (INCLUDING BUT NOT LIMITED TO THE RARE GENETIC DISORDER BIRT-HOGG-DUB? SYNDROME AND THE RARE CANCER OSTEOSARCOMA) AND THE FREE DISSEMINATION OF THE RESULTS OF SUCH RESEARCH TO THE PUBLIC3.2 THE ADVANCEMENT OF EDUCATION OF THE PUBLIC IN MEDICAL AND MOLECULAR GENETICS3.3 TO ASSIST IN THE RELIEF OF FINANCIAL HARDSHIP, TREATMENT AND CARE OF PERSONS SUFFERING FROM RARE DISORDERS, INCLUDING BUT NOT LIMITED TO BIRT HOGG DUBE SYNDROME AND OSTEOSARCOMA, THROUGH THE PROVISION OF GRANTS, GOODS AND SERVICES
Financial health, per its FY2024 accounts
The accounts state that the charity's unrestricted funds have decreased to a deficit of £297,005 as of March 2024, following significant grant funding expenditures. The trustees report that the charity has adequate resources to continue in operational existence for the foreseeable future and have adopted the going concern basis. The charity operates a defined contribution pension scheme and has no disclosed trading subsidiaries.
What the accounts disclose
“The Trustees aim to maintain free reserves in unrestricted funds at a level which equates to approximately three to six months of operational costs.” — page 9
Insolvency history (Companies House)
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Paying staff
- Risk management
- Safeguarding policy and procedures
- Safeguarding vulnerable beneficiaries
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/03/2024
- Employees paid over £60,000: 1 (£60,001–£70,000: 1)
Self-declared on the annual return for the financial year ending 30/09/2022
- Employees paid over £60,000: 1 (£60,001–£70,000: 1)
- Has a trading subsidiary
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 30/09/2021
- Employees paid over £60,000: 1 (£60,001–£70,000: 1)
- Has a trading subsidiary
- Grant-making is its main activity
Annual return filing dates (Charity Commission record)
Of its last 4 annual returns with a recorded received date, 1 was received after the due date: year ending 30/09/2020 (received 09/08/2021, 10 days after the 30/07/2021 due date).
1 further annual return is past its due date with no recorded received date (Charity Commission register).
Corporate structure
- Registered company of the charity Companies House 06369701 · Financial health read from its filings
Company officers (Companies House)
- OKORO, Grace Ugochi on trustee list
- BHAGWAT, Amit on trustee list
- PANAGOPOULOS, Dimitris Nikolas not on trustee list
- HONEYWOOD, Katie Alexandra
Structured financials (annual return, FY ending 31/03/2024)
Trustees
- Amit Bhagwat
- Dr Grace Okoro
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | — | — |
| 31/03/2024 | £594k | £900k |
| 30/09/2022 | £342k | £332k |
| 30/09/2021 | £159k | £145k |
| 30/09/2020 | £323k | £348k |
Common questions
Is MYROVLYTIS TRUST financially healthy?
Per its FY2024 accounts: The accounts state that the charity's unrestricted funds have decreased to a deficit of £297,005 as of March 2024, following significant grant funding expenditures. The trustees report that the charity has adequate resources to continue in operational existence for the foreseeable future and have adopted the going concern basis. The charity operates a defined contribution pension scheme and has no disclosed trading subsidiaries. Its FY2024 accounts were independently examined.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE CAPRICORN FOUNDATION | 1 | £275k |
| THE EVELYN TRUST | 1 | £182k |
| H P CHARITABLE TRUST | 1 | £1k |
Charities like this
- MYOSITIS UK
- THE MARY KINROSS CHARITABLE TRUST
- The Trust Foundation
- THE ANYA STURDY CHARITABLE TRUST FOR MEDICAL RESEARCH
- MYELOPATHY.ORG
- MYR CHARITABLE TRUST
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| MYROVLYTIS TRUST | £594k | — | 0 | unclear | — | no doubt |
| MYOSITIS UK | £140k | — | 0 | unclear | — | no doubt |
| THE MARY KINROSS CHARITABLE TRUST | £1.5m | — | — | unclear | — | no doubt |
| The Trust Foundation | £2.5m | — | 0 | unclear | — | no doubt |
| THE ANYA STURDY CHARITABLE TRUST FOR MEDICAL RESEARCH | £70k | — | 0 | unclear | — | no doubt |
| MYELOPATHY.ORG | £93k | — | 0 | above | — | no doubt |